Immunotherapy plus induction chemotherapy followed by radiotherapy alone or one cycle of concurrent chemotherapy with cisplatin vs induction chemotherapy followed by two cycles of concurrent chemotherapy with cisplatin in locoregionally advanced nasopharyngeal carcinoma - Scorecard - MDSpire

Immunotherapy plus induction chemotherapy followed by radiotherapy alone or one cycle of concurrent chemotherapy with cisplatin vs induction chemotherapy followed by two cycles of concurrent chemotherapy with cisplatin in locoregionally advanced nasopharyngeal carcinoma

  • By

  • Renba Liang

  • Xinxiao Li

  • Manyi Zhu

  • Fengming Lan

  • Fangmeng Fu

  • Ling Lei

  • Teng Zou

  • Li Ma

  • Peng Chen

  • Lingzhi Luo

  • Jing Jin

  • Jianghu Zhang

  • May 25, 2026

  • 0 min

Share

Clinical Scorecard: Comparative Analysis of Immunotherapy with Induction Chemotherapy and Radiotherapy Versus Induction Chemotherapy with Two Cycles of Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

At a Glance

CategoryDetail
Condition
Key MechanismsImmunotherapy combined with induction chemotherapy followed by radiotherapy or concurrent chemoradiotherapy (source needed).
Target Population
Care Setting

Key Highlights

  • Remove phrases that imply conclusions or clinical implications not stated in the source.

Guideline-Based Recommendations

Diagnosis

    Management

    • Ensure all recommendations are directly supported by the study.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Patients aged ≥18 years with locally advanced nasopharyngeal carcinoma

        Combination of immunotherapy and induction chemotherapy may improve EFS with lower adverse events

        Clinical Best Practices

        • Remove unsupported practices or ensure they are directly sourced.

        Related Resources & Content

        Original Source(s)

        Related Content